PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC)

• Laura M. Stinton ,

  * E-mail: laura.stinton@ucalgary.ca

  Affiliation Department of Medicine, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Chelsea Bentow,

  Affiliation Inova Diagnostics, Inc., San Diego, California, United States of America

  ⨯
• Michael Mahler,

  Affiliation Inova Diagnostics, Inc., San Diego, California, United States of America

  ⨯
• Gary L. Norman,

  Affiliation Inova Diagnostics, Inc., San Diego, California, United States of America

  ⨯
• Bertus Eksteen,

  Affiliation Department of Medicine, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Andrew L. Mason,

  Affiliation Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

  ⨯
• Gilaad G. Kaplan,

  Affiliation Department of Medicine, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Bjorn Lindkvist,

  Affiliation Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Gideon M. Hirschfield,

  Affiliation Centre for Liver Research, NIHR Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Piotr Milkiewicz,

  Affiliations Department of General, Transplant and Liver Surgery, Warsaw Medical University, Warsaw, Poland, Liver Research Laboratories, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Angela Cheung,

  Affiliation University Health Network, Division of Gastroenterology, Toronto Western Hospital, Toronto, Ontario, Canada

  ⨯
• Harry L. A. Janssen,

  Affiliation University Health Network, Division of Gastroenterology, Toronto Western Hospital, Toronto, Ontario, Canada

  ⨯
• Marvin J. Fritzler

  Affiliation Department of Medicine, University of Calgary, Calgary, Alberta, Canada

  ⨯